Expression of a transgene encoded on a non-viral episomal vector is not subject to epigenetic silencing by cytosine methylation

被引:45
作者
Jenke, ACW
Scinteie, MF
Stehle, IM
Lipps, HJ [1 ]
机构
[1] Univ Witten Herdecke, Inst Cell Biol, Witten, Germany
[2] Univ Witten Herdecke, Helios Children Hosp, Wuppertal, Germany
关键词
non-viral vector; episome; long-term expression; cytosine methylation;
D O I
10.1023/B:MOLE.0000031363.35839.46
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Currently available vectors for mammalian cells suffer from a number of limitations which make them only partially useful for genetic modification of eukaryotic cells and organisms and for gene therapy. While integration of a vector can lead to unpredictable interactions with the host genome and silencing of the integrated transgene, most non-integrating vectors mediate only transient expression of a transgene. All available vector types can lead to transformation of the recipient cell and many of them can cause serious immunological side effects in the organism. The ideal vector has to be free of these side effects and should allow long-term expression of a transgene in the absence of selection. In this report we describe a novel non-viral episomal expression system fulfilling these criteria. The gene encoding the truncated rat NGF-receptor gene under the control of the CMV-promoter was inserted into a vector construct containing a scaffold/matrix attached region (S/MAR). This vector was then transfected into CHO cells and human HaCat cells. We show that this vector replicates episomally in these cells and is mitotically stable in the abscence of selection over more than 100 generations. Moreover, we provide the first experimental data that the CMV-promoter in an episome is not subject to silencing by cytosine methylation, thus allowing long-term expression of the transgene in the absence of selection.
引用
收藏
页码:85 / 90
页数:6
相关论文
共 19 条
[1]   Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix [J].
Baiker, A ;
Maercker, C ;
Piechaczek, C ;
Schmidt, SBA ;
Bode, J ;
Benham, C ;
Lipps, HJ .
NATURE CELL BIOLOGY, 2000, 2 (03) :182-184
[2]   NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[3]   Gene therapy - Shining hopes dented - but not dashed [J].
Check, E .
NATURE, 2002, 420 (6917) :735-735
[4]   Modulation of plasmid DNA methylation and expression in zebrafish embryos [J].
Collas, P .
NUCLEIC ACIDS RESEARCH, 1998, 26 (19) :4454-4461
[5]   Human beta interferon scaffold attachment region inhibits de novo methylation and confers long-term, copy number-dependent expression to a retroviral vector [J].
Dang, Q ;
Auten, J ;
Plavec, I .
JOURNAL OF VIROLOGY, 2000, 74 (06) :2671-2678
[6]   TEMPERATURE-SENSITIVE MUTANTS OF POLYOMA VIRUS [J].
DIMAYORCA, G ;
CALLENDER, J ;
MARIN, G ;
GIORDANO, R .
VIROLOGY, 1969, 38 (01) :126-+
[7]   An episomally replicating vector binds to the nuclear matrix protein SAF-A in vivo [J].
Jenke, BHC ;
Fetzer, CP ;
Stehle, IM ;
Jönsson, F ;
Fackelmayer, FO ;
Conradt, H ;
Bode, J ;
Lipps, HJ .
EMBO REPORTS, 2002, 3 (04) :349-354
[8]   Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics [J].
Kay, MA ;
Glorioso, JC ;
Naldini, L .
NATURE MEDICINE, 2001, 7 (01) :33-40
[9]   Chromosome-based vectors for gene therapy [J].
Lipps, HJ ;
Jenke, ACW ;
Nehlsen, K ;
Scinteie, MF ;
Stehle, IM ;
Bode, J .
GENE, 2003, 304 :23-33
[10]   Gene therapy - What to do when clear success comes with an unclear risk? [J].
Marshall, E .
SCIENCE, 2002, 298 (5593) :510-511